{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:42:49Z","timestamp":1788378169471,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Nosocomial and community acquired multidrug resistant<jats:italic>Klebsiella<\/jats:italic>infections are wide spread resulting in high morbidity and mortality due to limited number of antibiotics treatment options. This study investigated efflux pump activity, biofilm forming potential and antibiotic susceptibility profile of<jats:italic>Klebsiella<\/jats:italic>spp. isolated from clinical samples in a tertiary hospital in Lagos Nigeria. Eighteen clinical<jats:italic>Klebsiella<\/jats:italic>spp. isolated from urine, blood and sputum were subjected to antibiotic susceptibility testing using the disc diffusion method. Efflux pump activity was evaluated by the ethidium bromide cartwheel method and biofilm forming ability was determined by the tissue culture plate technique.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All 18 (100%)<jats:italic>Klebsiella<\/jats:italic>isolates were resistant to cefuroxime, cefixime, amoxicillin\u2009\u2212\u2009clavulanate, ampicillin\u2009+\u2009cloxacillin, cefotaxime, and imipenem. Seventeen (94.4%) were resistant to ofloxacin while sixteen (88.9%) were resistance to nalidixic acid, Gentamicin and levofloxacin. All<jats:italic>Klebsiella<\/jats:italic>isolates possessed active efflux pump with the ability to form biofilm. However, their biofilm forming capabilities varied as 4 (22.2%) were strong, 3 (16.7%) were moderate and 11 (61.1%) were weak biofilm formers. Findings in this study reveal multiple factors at play in mediating the high level of antibiotic resistance observed in<jats:italic>Klebsiella<\/jats:italic>isolates. Hence a multifaceted approach is advocated in managing the infections caused by the pathogen.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13104-020-05105-2","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T08:02:59Z","timestamp":1590480179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital"],"prefix":"10.1186","volume":"13","author":[{"given":"Sharon","family":"Akinpelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella I.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeyemi I.","family":"Adeleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"issue":"4","key":"5105_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/CMR.11.4.589","volume":"11","author":"R Podschun","year":"1998","unstructured":"Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589\u2013603.","journal-title":"Clin Microbiol Rev"},{"key":"5105_CR2","first-page":"118","volume":"4","author":"R Omoregie","year":"2012","unstructured":"Omoregie R, Igbarumah IO, Egbe CA, Ogefere OH. Urinary tract infection among neonates in Benin City Nigeria. GMBHS. 2012;4:118\u201321.","journal-title":"GMBHS"},{"key":"5105_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12866-019-1593-5","volume":"19","author":"J Li","year":"2019","unstructured":"Li J, Huang Z-Y, Yu T, Tao X-Y, Hu Y-M, Wang HC, Zou M-X. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from mid-south region of China. BMC Microbiol. 2019;19:219.","journal-title":"BMC Microbiol"},{"issue":"2","key":"5105_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuy043","volume":"43","author":"JA Bengoechea","year":"2019","unstructured":"Bengoechea JA, Pessoa JS. Klebsiella pneumoniae infection biology: living to counteract host defenses. FEMS Microbiol Rev. 2019;43(2):123\u201344.","journal-title":"FEMS Microbiol Rev"},{"key":"5105_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jiph.2014.05.002","volume":"7","author":"S Rath","year":"2014","unstructured":"Rath S, Padhy RN. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community. J Infect Public Heal. 2014;7:496\u2013507.","journal-title":"J Infect Public Heal"},{"issue":"1","key":"5105_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4314\/ajid.v10i1.7","volume":"10","author":"A Fadeyi","year":"2016","unstructured":"Fadeyi A, Zumuk CP, Raheem RA, Nwabuisi C, Desalu OO. Prevalence and antibiotic susceptibility pattern of ESBL producing Klebsiellae isolated from clinical specimens in a Nigerian tertiary hospital. Afr J Infect Dis. 2016;10(1):32\u20137.","journal-title":"Afr J Infect Dis"},{"key":"5105_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13104-019-4084-8","volume":"12","author":"R Dumaru","year":"2019","unstructured":"Dumaru R, Baral R, Shrestha LB. Study of biofilm formation and antibiotic resistance pattern of Gram negative bacilli among the clinical isolates at BPKIHS, Dharan. BMC Res Notes. 2019;12:38.","journal-title":"BMC Res Notes"},{"key":"5105_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/antibiotics8040229","volume":"8","author":"A Reza","year":"2019","unstructured":"Reza A, Sutton JM, Rahman KM. Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in Gram negative (ESKAPEE) bacteria. Antibiotics. 2019;8:229.","journal-title":"Antibiotics"},{"key":"5105_CR9","first-page":"171","volume":"25","author":"M Martins","year":"2011","unstructured":"Martins M, Viveiros M, Couto I, Costa SS, Pacheco T, Fanning S, Pages J-M, Amaral L. Identification of efflux pump mediated multidrug resistant bacteria by ethidium bromide agar cartwheel method. In vivo. 2011;25:171\u20138.","journal-title":"In vivo"},{"key":"5105_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/CBO9780511543470","volume-title":"Escherichia coli District laboratory practice in tropical countries, Part 2","author":"M Cheesebrough","year":"2006","unstructured":"Cheesebrough M. Escherichia coli District laboratory practice in tropical countries, Part 2. 2nd ed. London: Cambridge University Press; 2006. p. 178\u201380.","edition":"2"},{"key":"5105_CR11","unstructured":"EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Break point tables for interpretation of MICs and zone diameters version 9.0. 2019; http:\/\/www.eucast.org. Accessed 10 July 2019."},{"issue":"2","key":"5105_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-7012(00)00122-6","volume":"40","author":"S Stephanovic","year":"2000","unstructured":"Stephanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic B. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175\u20139.","journal-title":"J Microbiol Methods"},{"key":"5105_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/pathogens3030743","volume":"3","author":"C Vuotto","year":"2014","unstructured":"Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathog. 2014;3:743\u201358.","journal-title":"Pathog"},{"key":"5105_CR14","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.12688\/f1000research.11532.1","volume":"6","author":"DP Calfee","year":"2017","unstructured":"Calfee DP. Recent advances in the understanding and management of Klebsiella pneumoniae [version 1; referees: 2 approved]. F1000 Res. 2017;6:1760.","journal-title":"F1000 Res."},{"issue":"1","key":"5105_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/jac\/dki429","volume":"57","author":"OO Soge","year":"2006","unstructured":"Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother. 2006;57(1):24\u201330.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5105_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5539\/gjhs.v5n2p187","volume":"5","author":"FD Otajevwo","year":"2013","unstructured":"Otajevwo FD. Urinary tract infection among symptomatic outpatients visiting a tertiary hospital based in Midwestern Nigeria. Glob J Health Sci. 2013;5(2):187\u201399.","journal-title":"Glob J Health Sci"},{"key":"5105_CR17","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.2147\/IDR.S178243","volume":"11","author":"PA Akinduti","year":"2018","unstructured":"Akinduti PA, Olasehinde GI, Ejilude O, Taiwo OS, Obafemi YD. Fecal carriage and phylodiversity of community acquired bla TEM Enteric bacilli in Southwest Nigeria. Infect Drug Resist. 2018;11:2425\u201333.","journal-title":"Infect Drug Resist"},{"key":"5105_CR18","first-page":"104","volume":"7","author":"AGN Oli","year":"2019","unstructured":"Oli AGN, Ogbuagu VI, Ejikeugwu CP, Iroha IR, Ugwu MC, Ofomata CM, Okeke KN, Emechebe GO, Okoro JC, Okani CO, Onah SK. Multi-antibiotic resistance and factors affecting carriage of extended spectrum \u03b2-lactamase-producing enterobacteriaceae in pediatric population of enugu metropolis, Nigeria. Med Sci. 2019;7:104.","journal-title":"Med Sci"},{"issue":"20","key":"5105_CR19","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.12998\/wjcc.v7.i20.3175","volume":"7","author":"W Huai","year":"2019","unstructured":"Huai W, Ma QB, Zheng JJ, Zhao Y, Zhai QR. Distribution and drug resistance of pathogenic bacteria in emergency patients. World J Clin Cases. 2019;7(20):3175\u201384.","journal-title":"World J Clin Cases"},{"key":"5105_CR20","doi-asserted-by":"publisher","first-page":"e02349","DOI":"10.1016\/j.heliyon.2019.e02349","volume":"5","author":"S Yazdansetad","year":"2019","unstructured":"Yazdansetad S, Alkhudhairy MK, Najafpour R, Farajtabrizi E, Al-Mosawi RM, Saki M, Jafarzadeh E, Izadpour F, Ameri A. Preliminary survey of extended-spectrum \u03b2-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran. Heliyon. 2019;5:e02349.","journal-title":"Heliyon"},{"key":"5105_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-018-0006-1","author":"A Humayun","year":"2018","unstructured":"Humayun A, Siddiqui FM, Akram N, Saleem S, Ali A, Iqbal T, Kumar A, Kamran R, Bokhari H. Incidence of metallo-beta-lactamase-producing Klebsiella pneumoniae isolates from hospital setting in Pakistan. Int Microbiol. 2018. https:\/\/doi.org\/10.1007\/s10123-018-0006-1.","journal-title":"Int Microbiol"},{"key":"5105_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4271638","author":"O Szabo","year":"2018","unstructured":"Szabo O, Kocsis B, Szabo N, Kristof K, Szabo D. Contribution of OqxAB Efflux Pump in Selection of Fluoroquinolone-Resistant Klebsiella pneumoniae. Can J Infect Dis Med Microbiol. 2018. https:\/\/doi.org\/10.1155\/2018\/4271638.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"8","key":"5105_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1089\/mdr.2018.0414","volume":"25","author":"N Maurya","year":"2019","unstructured":"Maurya N, Jangra M, Tambat R, Nandanwar H. Alliance of efflux pumps with \u03b2-Lactamases in multidrug-resistant Klebsiella pneumoniae isolates. Microb Drug Resist. 2019;25(8):1155\u201363.","journal-title":"Microb Drug Resist"},{"key":"5105_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12919-019-0176-7","volume":"13","author":"H Nirwati","year":"2019","unstructured":"Nirwati H, Sinanjung K, Fahrunissa F, Wijaya F, Napitupulu S, Hati VP, Hakim MS, Meliala A, Aman AT, Nuryastuti T. Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. BMC Proc. 2019;13:20.","journal-title":"BMC Proc."},{"key":"5105_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7012958","author":"MD Alc\u00e1ntar-Curiel","year":"2018","unstructured":"Alc\u00e1ntar-Curiel MD, Ledezma-Escalante CA, Jarillo-Quijada MD, Gayosso-V\u00e1zquez C, Morf-n-Otero R, Rodr-guez-Noriega E, Cedillo-Ram-rez ML, Santos-Preciado JI, Gir\u00f3n JA. Association of antibiotic resistance, cell adherence, and biofilm production with the endemicity of nosocomial Klebsiella pneumoniae. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/7012958.","journal-title":"Biomed Res Int"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05105-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:33:18Z","timestamp":1696167198000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5105"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05105-2","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Institutional Review Board, Nigerian Institute of Medical Research with code number IRBB\/19\/033.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}